User profiles for Kristel Leung
Kristel LeungClinical Associate, Hepatologist, PhD Student, Toronto Centre for Liver Disease Verified email at mail.utoronto.ca Cited by 206 |
Systematic review with meta‐analysis: risk of adverse pregnancy‐related outcomes in inflammatory bowel disease
Background The effect of inflammatory bowel disease (IBD) on pregnancy‐related outcomes
remains unknown. Aim To determine the risk of adverse maternal, placental and obstetric …
remains unknown. Aim To determine the risk of adverse maternal, placental and obstetric …
pathophysiology and management of primary biliary cholangitis
Background Primary biliary cholangitis (PBC), an immune‐mediated disease characterised
by destruction of intrahepatic bile ducts, results in progressive damage to the biliary tree, …
by destruction of intrahepatic bile ducts, results in progressive damage to the biliary tree, …
Noninvasive methods for assessing inflammatory bowel disease activity in pregnancy: a systematic review
Active inflammatory bowel disease (IBD) may increase the risk of adverse outcomes during
pregnancy. Our aim was to systematically review the role of noninvasive fecal tests, such as …
pregnancy. Our aim was to systematically review the role of noninvasive fecal tests, such as …
The risk of adverse neonatal outcomes with maternal inflammatory bowel disease: a systematic review and meta-analysis
Background Patients with inflammatory bowel disease (IBD) may be at increased risk of
adverse neonatal outcomes. The aim of this study was to determine pooled incidences and risk …
adverse neonatal outcomes. The aim of this study was to determine pooled incidences and risk …
Gender differences in gastroenterology and hepatology authorship and editorial boards
KK Leung, N Jawaid, N Bollegala - Gastrointestinal Endoscopy, 2021 - Elsevier
Background and Aims Women are numerically under-represented in the field of gastroenterology
and hepatology. This study aims to characterize the gender distribution of first and …
and hepatology. This study aims to characterize the gender distribution of first and …
Autoantibodies in primary biliary cholangitis
KK Leung, GM Hirschfield - Clinics in Liver Disease, 2022 - liver.theclinics.com
Primary biliary cholangitis (PBC) is a chronic immune-mediated liver disease with an
estimated global prevalence of 14.6 per 100,000 population (range from 1.91 to 40.2). 1, 2 …
estimated global prevalence of 14.6 per 100,000 population (range from 1.91 to 40.2). 1, 2 …
The impact of primary liver disease and social determinants in a mixed donor liver transplant program: a single‐center analysis
Organ allocation in liver transplantation (LT) remains imperfect. Periodic center reviews
ensure programs transparently evaluate the impact of practice on access to transplantation, …
ensure programs transparently evaluate the impact of practice on access to transplantation, …
Recurrent primary sclerosing cholangitis: current understanding, management, and future directions
Patients with primary sclerosing cholangitis (PSC) constitute 5 to 15% of patients listed for
liver transplantation worldwide. Although post-transplant outcomes are favorable, recurrent …
liver transplantation worldwide. Although post-transplant outcomes are favorable, recurrent …
[HTML][HTML] Long-term outcomes of liver transplant recipients followed up in non-transplant centres: Care closer to home
…, N Palaniyappan, P Wijayasiri, K Leung… - Clinical …, 2021 - ncbi.nlm.nih.gov
Methods A retrospective analysis of all adult patients who underwent liver transplantation
between 1987 and 2016, with post-transplant follow-up in two non-transplant centres in the UK …
between 1987 and 2016, with post-transplant follow-up in two non-transplant centres in the UK …
Esophageal Stenting as Bridge Therapy to Direct Intrahepatic Portocaval Shunt for Refractory Variceal Bleeding
Discussion Covered esophageal stenting can be a bridge to more definitive therapy such as
TIPS or liver transplantation for refractory bleeding with high clinical success.(1) Stents …
TIPS or liver transplantation for refractory bleeding with high clinical success.(1) Stents …